- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Dumont and Kampmann among seven UCSF recipients of NIH High-Risk, High-Reward grants
By Rebecca Dawson / Thu Dec 3, 2015
In October, the National Institutes of Health (NIH) announced the award of seven grants to UC San Francisco scientists through the highly competitive High-Risk, High-Reward Research program, supported by the NIH Common Fund. These grants are reserved for researchers with the most creative approaches to major biomedical challenges. Awardees included Jeffrey S. Cox, Sophie Dumont, Karunesh Ganguly, Martin Kampmann, Zachary Knight, Joseph Bondy-Denomy, and David Solomon. Seventy-eight such grants were awarded to U.S. researchers.
More
NIH Awards ‘High-Risk, High-Reward’ Grants to Seven UCSF Researchers
Tags
Category:
Sites:
Biophysics
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
Related news
- Shipman receives NIH Director’s New Innovator Award
- Danica Fujimori Receives Bowes Biomedical Investigator Award
- QBI pioneers a collaborative and inclusive approach to scientific discovery
- From haircuts to high blood pressure management
- School of Pharmacy faculty recognized among Highly Cited Researchers
